Diagnosis and treatment of fanconi's anemia

The novel FLJ11011 gene encoding a human ubiquitin-conjugating (E2) enzyme as well as gene fragments, coding sequences, mRNA variants and encoded proteins are disclosed. Additionally, methods of diagnosing and treating a patient that has or is suspected of having Fanconi's anemia or increased s...

Full description

Saved in:
Bibliographic Details
Main Authors SU TIN TIN, DUNCAN TOD
Format Patent
LanguageEnglish
Published 30.03.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The novel FLJ11011 gene encoding a human ubiquitin-conjugating (E2) enzyme as well as gene fragments, coding sequences, mRNA variants and encoded proteins are disclosed. Additionally, methods of diagnosing and treating a patient that has or is suspected of having Fanconi's anemia or increased susceptibility to cancer or diminished capability of DNA repair. Additionally, methods of identifying compounds with the potential to treat or ameliorate Fanconi's Anemia are provided.
Bibliography:Application Number: US20050203033